-
1
-
-
0033518231
-
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant
-
Wolfe RA, Ashby VB, Milford EL, et al,. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
-
(1999)
N Engl J Med
, vol.341
, pp. 1725
-
-
Wolfe, R.A.1
Ashby, V.B.2
Milford, E.L.3
-
2
-
-
0031728260
-
Impact of renal cadaveric transplantation on survival in end-stage renal failure: Evidence for reduced mortality risk compared with hemodialysis during long-term follow-up
-
Schnuelle P, Lorenz D, Trede M, Van Der Woude FJ,. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol 1998; 9: 2135.
-
(1998)
J Am Soc Nephrol
, vol.9
, pp. 2135
-
-
Schnuelle, P.1
Lorenz, D.2
Trede, M.3
Van Der Woude, F.J.4
-
3
-
-
0027305120
-
Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients
-
Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K,. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 1993; 270: 1339.
-
(1993)
JAMA
, vol.270
, pp. 1339
-
-
Port, F.K.1
Wolfe, R.A.2
Mauger, E.A.3
Berling, D.P.4
Jiang, K.5
-
4
-
-
0028352530
-
Comparative mortality risks of chronic dialysis and cadaveric transplantation in black end-stage renal disease patients
-
Ojo AO, Port FK, Wolfe RA, Mauger EA, Williams L, Berling DP,. Comparative mortality risks of chronic dialysis and cadaveric transplantation in black end-stage renal disease patients. Am J Kidney Dis 1994; 24: 59.
-
(1994)
Am J Kidney Dis
, vol.24
, pp. 59
-
-
Ojo, A.O.1
Port, F.K.2
Wolfe, R.A.3
Mauger, E.A.4
Williams, L.5
Berling, D.P.6
-
5
-
-
0031843670
-
Renal transplantation: Access and outcomes. United States Renal Data System
-
Renal transplantation: access and outcomes. United States Renal Data System. Am J Kidney Dis 1998; 32: S89.
-
(1998)
Am J Kidney Dis
, vol.32
-
-
-
6
-
-
0033919448
-
Long-term survival of renal transplant recipients in the United States after acute myocardial infarction
-
Herzog CA, Ma JZ, Collins AJ,. Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. Am J Kidney Dis 2000; 36: 145.
-
(2000)
Am J Kidney Dis
, vol.36
, pp. 145
-
-
Herzog, C.A.1
Ma, J.Z.2
Collins, A.J.3
-
7
-
-
0037182904
-
The changing causes of graft loss and death after kidney transplantation
-
Howard RJ, Patton PR, Reed AI, et al,. The changing causes of graft loss and death after kidney transplantation. Transplantation 2002; 73: 1923.
-
(2002)
Transplantation
, vol.73
, pp. 1923
-
-
Howard, R.J.1
Patton, P.R.2
Reed, A.I.3
-
8
-
-
19944382299
-
Incidence and predictors of myocardial infarction after kidney transplantation
-
Lentine KL, Brennan DC, Schnitzler MA,. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 2005; 16: 496.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 496
-
-
Lentine, K.L.1
Brennan, D.C.2
Schnitzler, M.A.3
-
9
-
-
0034871856
-
Causes of death after renal transplantation
-
Briggs JD,. Causes of death after renal transplantation. Nephrol Dial Transplant 2001; 16: 1545.
-
(2001)
Nephrol Dial Transplant
, vol.16
, pp. 1545
-
-
Briggs, J.D.1
-
10
-
-
0034005754
-
Long-term survival in renal transplant recipients with graft function
-
Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK,. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000; 57: 307.
-
(2000)
Kidney Int
, vol.57
, pp. 307
-
-
Ojo, A.O.1
Hanson, J.A.2
Wolfe, R.A.3
Leichtman, A.B.4
Agodoa, L.Y.5
Port, F.K.6
-
11
-
-
0036407148
-
Mortality after kidney transplant failure: The impact of non-immunologic factors
-
Gill JS, Abichandani R, Kausz AT, Pereira BJ,. Mortality after kidney transplant failure: the impact of non-immunologic factors. Kidney Int 2002; 62: 1875.
-
(2002)
Kidney Int
, vol.62
, pp. 1875
-
-
Gill, J.S.1
Abichandani, R.2
Kausz, A.T.3
Pereira, B.J.4
-
12
-
-
29544441335
-
Risk factors for cardiovascular disease during the first 2 years after renal transplantation
-
Laures AS, Gomez E, Baltar J, Alvarez-Grande J,. Risk factors for cardiovascular disease during the first 2 years after renal transplantation. Transplant Proc 2005; 37: 3778.
-
(2005)
Transplant Proc
, vol.37
, pp. 3778
-
-
Laures, A.S.1
Gomez, E.2
Baltar, J.3
Alvarez-Grande, J.4
-
13
-
-
3142570571
-
Predictors of cardiovascular events and associated mortality within two years of kidney transplantation
-
Chuang P, Gibney EM, Chan L, Ho PM, Parikh CR,. Predictors of cardiovascular events and associated mortality within two years of kidney transplantation. Transplant Proc 2004; 36: 1387.
-
(2004)
Transplant Proc
, vol.36
, pp. 1387
-
-
Chuang, P.1
Gibney, E.M.2
Chan, L.3
Ho, P.M.4
Parikh, C.R.5
-
14
-
-
0033918552
-
Endothelial dysfunction in renal transplant recipients maintained on cyclosporine
-
Morris ST, McMurray JJ, Rodger RS, Farmer R, Jardine AG,. Endothelial dysfunction in renal transplant recipients maintained on cyclosporine. Kidney Int 2000; 57: 1100.
-
(2000)
Kidney Int
, vol.57
, pp. 1100
-
-
Morris, S.T.1
McMurray, J.J.2
Rodger, R.S.3
Farmer, R.4
Jardine, A.G.5
-
15
-
-
72949116149
-
Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients
-
Abedini S, Meinitzer A, Holme I, et al,. Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients. Kidney Int 2010; 77: 44.
-
(2010)
Kidney Int
, vol.77
, pp. 44
-
-
Abedini, S.1
Meinitzer, A.2
Holme, I.3
-
16
-
-
0030460424
-
Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
-
Davis S, Aldrich TH, Jones PF, et al,. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996; 87: 1161.
-
(1996)
Cell
, vol.87
, pp. 1161
-
-
Davis, S.1
Aldrich, T.H.2
Jones, P.F.3
-
17
-
-
15144358851
-
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
-
Maisonpierre PC, Suri C, Jones PF, et al,. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55.
-
(1997)
Science
, vol.277
, pp. 55
-
-
Maisonpierre, P.C.1
Suri, C.2
Jones, P.F.3
-
18
-
-
0030480322
-
Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
-
Suri C, Jones PF, Patan S, et al,. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996; 87: 1171.
-
(1996)
Cell
, vol.87
, pp. 1171
-
-
Suri, C.1
Jones, P.F.2
Patan, S.3
-
19
-
-
84874568733
-
Angiopoietin-2 is associated with albuminuria and microinflammation in chronic kidney disease
-
Chang FC, Lai TS, Chiang CK, et al,. Angiopoietin-2 is associated with albuminuria and microinflammation in chronic kidney disease. PLoS ONE 2013; 8: e54668.
-
(2013)
PLoS ONE
, vol.8
-
-
Chang, F.C.1
Lai, T.S.2
Chiang, C.K.3
-
20
-
-
84873626036
-
Circulating angiopoietin-2 is a marker for early cardiovascular disease in children on chronic dialysis
-
Shroff RC, Price KL, Kolatsi-Joannou M, et al,. Circulating angiopoietin-2 is a marker for early cardiovascular disease in children on chronic dialysis. PLoS ONE 2013; 8: e56273.
-
(2013)
PLoS ONE
, vol.8
-
-
Shroff, R.C.1
Price, K.L.2
Kolatsi-Joannou, M.3
-
21
-
-
33646780950
-
Signaling and functions of angiopoietin-1 in vascular protection
-
Brindle NP, Saharinen P, Alitalo K,. Signaling and functions of angiopoietin-1 in vascular protection. Circ Res 2006; 98: 1014.
-
(2006)
Circ Res
, vol.98
, pp. 1014
-
-
Brindle, N.P.1
Saharinen, P.2
Alitalo, K.3
-
22
-
-
33751225092
-
Angiopoietins: A link between angiogenesis and inflammation
-
Fiedler U, Augustin HG,. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol 2006; 27: 552.
-
(2006)
Trends Immunol
, vol.27
, pp. 552
-
-
Fiedler, U.1
Augustin, H.G.2
-
23
-
-
84888301087
-
The angiopoietin:Tie 2 interaction: A potential target for future therapies in human vascular disease
-
Moss A,. The angiopoietin:Tie 2 interaction: a potential target for future therapies in human vascular disease. Cytokine Growth Factor Rev 2013; 24: 579.
-
(2013)
Cytokine Growth Factor Rev
, vol.24
, pp. 579
-
-
Moss, A.1
-
24
-
-
0036181270
-
The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis
-
Kontos CD, Cha EH, York JD, Peters KG,. The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis. Mol Cell Biol 2002; 22: 1704.
-
(2002)
Mol Cell Biol
, vol.22
, pp. 1704
-
-
Kontos, C.D.1
Cha, E.H.2
York, J.D.3
Peters, K.G.4
-
25
-
-
0037418914
-
The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN-2
-
Hughes DP, Marron MB, Brindle NP,. The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN-2. Circ Res 2003; 92: 630.
-
(2003)
Circ Res
, vol.92
, pp. 630
-
-
Hughes, D.P.1
Marron, M.B.2
Brindle, N.P.3
-
26
-
-
68449100599
-
Angiopoietins in arterial hypertension: A mechanism of adaptation or a target for treatment?
-
Shantsila E, Lip GY,. Angiopoietins in arterial hypertension: a mechanism of adaptation or a target for treatment? J Hypertens 2009; 27: 1524.
-
(2009)
J Hypertens
, vol.27
, pp. 1524
-
-
Shantsila, E.1
Lip, G.Y.2
-
27
-
-
60749096085
-
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system
-
Augustin HG, Koh GY, Thurston G, Alitalo K,. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 2009; 10: 165.
-
(2009)
Nat Rev Mol Cell Biol
, vol.10
, pp. 165
-
-
Augustin, H.G.1
Koh, G.Y.2
Thurston, G.3
Alitalo, K.4
-
28
-
-
84875807200
-
The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway
-
Thurston G, Daly C,. The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway. Cold Spring Harb Perspect Med 2012; 2: a006550.
-
(2012)
Cold Spring Harb Perspect Med
, vol.2
-
-
Thurston, G.1
Daly, C.2
-
29
-
-
2542453735
-
The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies
-
Fiedler U, Scharpfenecker M, Koidl S, et al,. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004; 103: 4150.
-
(2004)
Blood
, vol.103
, pp. 4150
-
-
Fiedler, U.1
Scharpfenecker, M.2
Koidl, S.3
-
30
-
-
0036493752
-
Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells
-
Huang YQ, Li JJ, Hu L, Lee M, Karpatkin S,. Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells. Blood 2002; 99: 1646.
-
(2002)
Blood
, vol.99
, pp. 1646
-
-
Huang, Y.Q.1
Li, J.J.2
Hu, L.3
Lee, M.4
Karpatkin, S.5
-
31
-
-
32244436305
-
Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation
-
Fiedler U, Reiss Y, Scharpfenecker M, et al,. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 2006; 12: 235.
-
(2006)
Nat Med
, vol.12
, pp. 235
-
-
Fiedler, U.1
Reiss, Y.2
Scharpfenecker, M.3
-
32
-
-
17044384530
-
Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: Relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis
-
Lim HS, Lip GY, Blann AD,. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis. Atherosclerosis 2005; 180: 113.
-
(2005)
Atherosclerosis
, vol.180
, pp. 113
-
-
Lim, H.S.1
Lip, G.Y.2
Blann, A.D.3
-
33
-
-
0037432292
-
Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis
-
Nykanen AI, Krebs R, Saaristo A, et al,. Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis. Circulation 2003; 107: 1308.
-
(2003)
Circulation
, vol.107
, pp. 1308
-
-
Nykanen, A.I.1
Krebs, R.2
Saaristo, A.3
-
34
-
-
6444222152
-
Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes
-
Lee KW, Lip GY, Blann AD,. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 2004; 110: 2355.
-
(2004)
Circulation
, vol.110
, pp. 2355
-
-
Lee, K.W.1
Lip, G.Y.2
Blann, A.D.3
-
35
-
-
70349406374
-
The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus
-
Kumpers P, David S, Haubitz M, et al,. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus. Ann Rheum Dis 2009; 68: 1638.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1638
-
-
Kumpers, P.1
David, S.2
Haubitz, M.3
-
36
-
-
57649116087
-
Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients
-
Kumpers P, Lukasz A, David S, et al,. Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 2008; 12: R147.
-
(2008)
Crit Care
, vol.12
-
-
Kumpers, P.1
Lukasz, A.2
David, S.3
-
37
-
-
33645355399
-
Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans
-
Parikh SM, Mammoto T, Schultz A, et al,. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006; 3: e46.
-
(2006)
PLoS Med
, vol.3
-
-
Parikh, S.M.1
Mammoto, T.2
Schultz, A.3
-
38
-
-
66249121829
-
Circulating angiopoietin-2 in essential hypertension: Relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/ pravastatin
-
David S, Kumpers P, Lukasz A, Kielstein JT, Haller H, Fliser D,. Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/ pravastatin. J Hypertens 2009; 27: 1641.
-
(2009)
J Hypertens
, vol.27
, pp. 1641
-
-
David, S.1
Kumpers, P.2
Lukasz, A.3
Kielstein, J.T.4
Haller, H.5
Fliser, D.6
-
39
-
-
80054868438
-
Stepwise increase of angiopoietin-2 serum levels is related to haemodynamic and functional impairment in stable chronic heart failure
-
Eleuteri E, Di Stefano A, Tarro Genta F, et al,. Stepwise increase of angiopoietin-2 serum levels is related to haemodynamic and functional impairment in stable chronic heart failure. Eur J Cardiovasc Prev Rehabil 2011; 18: 607.
-
(2011)
Eur J Cardiovasc Prev Rehabil
, vol.18
, pp. 607
-
-
Eleuteri, E.1
Di Stefano, A.2
Tarro Genta, F.3
-
40
-
-
84879488245
-
Angiopoietin-2 in adults with congenital heart disease and heart failure
-
Lukasz A, Beutel G, Kumpers P, et al,. Angiopoietin-2 in adults with congenital heart disease and heart failure. PLoS ONE 2013; 8: e66861.
-
(2013)
PLoS ONE
, vol.8
-
-
Lukasz, A.1
Beutel, G.2
Kumpers, P.3
-
41
-
-
77954764513
-
Circulating angiopoietin-2 levels increase with progress of chronic kidney disease
-
David S, Kumpers P, Lukasz A, et al,. Circulating angiopoietin-2 levels increase with progress of chronic kidney disease. Nephrol Dial Transplant 2010; 25: 2571.
-
(2010)
Nephrol Dial Transplant
, vol.25
, pp. 2571
-
-
David, S.1
Kumpers, P.2
Lukasz, A.3
-
42
-
-
64749097050
-
Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation
-
David S, Kumpers P, Hellpap J, et al,. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation. Am J Kidney Dis 2009; 53: 770.
-
(2009)
Am J Kidney Dis
, vol.53
, pp. 770
-
-
David, S.1
Kumpers, P.2
Hellpap, J.3
-
44
-
-
78649845904
-
Body mass index, waist circumference and mortality in kidney transplant recipients
-
Kovesdy CP, Czira ME, Rudas A, et al,. Body mass index, waist circumference and mortality in kidney transplant recipients. Am J Transplant 2010; 10: 2644.
-
(2010)
Am J Transplant
, vol.10
, pp. 2644
-
-
Kovesdy, C.P.1
Czira, M.E.2
Rudas, A.3
-
45
-
-
78650371013
-
Associations between serum leptin level and bone turnover in kidney transplant recipients
-
Kovesdy CP, Molnar MZ, Czira ME, et al,. Associations between serum leptin level and bone turnover in kidney transplant recipients. Clin J Am Soc Nephrol 2010; 5: 2297.
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, pp. 2297
-
-
Kovesdy, C.P.1
Molnar, M.Z.2
Czira, M.E.3
-
46
-
-
79958100841
-
Association between the malnutrition-inflammation score and post-transplant anaemia
-
Molnar MZ, Czira ME, Rudas A, et al,. Association between the malnutrition-inflammation score and post-transplant anaemia. Nephrol Dial Transplant 2011; 26: 2000.
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 2000
-
-
Molnar, M.Z.1
Czira, M.E.2
Rudas, A.3
-
47
-
-
77953688160
-
Evaluation of the malnutrition-inflammation score in kidney transplant recipients
-
Molnar MZ, Keszei A, Czira ME, et al,. Evaluation of the malnutrition-inflammation score in kidney transplant recipients. Am J Kidney Dis 2010; 56: 102.
-
(2010)
Am J Kidney Dis
, vol.56
, pp. 102
-
-
Molnar, M.Z.1
Keszei, A.2
Czira, M.E.3
-
48
-
-
79955990950
-
Association of the malnutrition-inflammation score with clinical outcomes in kidney transplant recipients
-
Molnar MZ, Czira ME, Rudas A, et al,. Association of the malnutrition-inflammation score with clinical outcomes in kidney transplant recipients. Am J Kidney Dis 2011; 58: 101.
-
(2011)
Am J Kidney Dis
, vol.58
, pp. 101
-
-
Molnar, M.Z.1
Czira, M.E.2
Rudas, A.3
-
49
-
-
20544433374
-
Baseline comorbidity in kidney transplant recipients: A comparison of comorbidity indices
-
Jassal SV, Schaubel DE, Fenton SS,. Baseline comorbidity in kidney transplant recipients: a comparison of comorbidity indices. Am J Kidney Dis 2005; 46: 136.
-
(2005)
Am J Kidney Dis
, vol.46
, pp. 136
-
-
Jassal, S.V.1
Schaubel, D.E.2
Fenton, S.S.3
-
50
-
-
65649142017
-
A new equation to estimate glomerular filtration rate
-
Levey AS, Stevens LA, Schmid CH, et al,. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604.
-
(2009)
Ann Intern Med
, vol.150
, pp. 604
-
-
Levey, A.S.1
Stevens, L.A.2
Schmid, C.H.3
-
51
-
-
0023092594
-
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
-
Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373.
-
(1987)
J Chronic Dis
, vol.40
, pp. 373
-
-
Charlson, M.E.1
Pompei, P.2
Ales, K.L.3
Mackenzie, C.R.4
-
52
-
-
58549106577
-
Marked variation in the definition and diagnosis of delayed graft function: A systematic review
-
Yarlagadda SG, Coca SG, Garg AX, et al,. Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant 2008; 23: 2995.
-
(2008)
Nephrol Dial Transplant
, vol.23
, pp. 2995
-
-
Yarlagadda, S.G.1
Coca, S.G.2
Garg, A.X.3
-
53
-
-
49749122134
-
Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: Development and clinical application of two new immunoassays
-
Lukasz A, Hellpap J, Horn R, et al,. Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays. Crit Care 2008; 12: R94.
-
(2008)
Crit Care
, vol.12
-
-
Lukasz, A.1
Hellpap, J.2
Horn, R.3
-
54
-
-
1542532754
-
A proportional hazards model for the subdistribution of competing risk
-
Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of competing risk. J Am Stat Assoc 1999; 94: 496.
-
(1999)
J Am Stat Assoc
, vol.94
, pp. 496
-
-
Fine, J.P.1
Gray, R.J.2
-
55
-
-
42149086469
-
Balance between angiopoietin-1 and angiopoietin-2 is in favor of angiopoietin-2 in atherosclerotic plaques with high microvessel density
-
Post S, Peeters W, Busser E, et al,. Balance between angiopoietin-1 and angiopoietin-2 is in favor of angiopoietin-2 in atherosclerotic plaques with high microvessel density. J Vasc Res 2008; 45: 244.
-
(2008)
J Vasc Res
, vol.45
, pp. 244
-
-
Post, S.1
Peeters, W.2
Busser, E.3
-
56
-
-
43749108198
-
Angiogenesis and the progress of vascular and tumor biology: A tribute to Judah Folkman
-
Benedetta Donati M, Gozdzikiewicz J,. Angiogenesis and the progress of vascular and tumor biology: a tribute to Judah Folkman. Thromb Haemost 2008; 99: 647.
-
(2008)
Thromb Haemost
, vol.99
, pp. 647
-
-
Benedetta Donati, M.1
Gozdzikiewicz, J.2
-
57
-
-
14944377120
-
The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism
-
Scharpfenecker M, Fiedler U, Reiss Y, Augustin HG,. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci 2005; 118: 771.
-
(2005)
J Cell Sci
, vol.118
, pp. 771
-
-
Scharpfenecker, M.1
Fiedler, U.2
Reiss, Y.3
Augustin, H.G.4
-
58
-
-
33846677486
-
Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes
-
Lee S, Kim W, Moon SO, et al,. Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes. Nephrol Dial Transplant 2007; 22: 396.
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 396
-
-
Lee, S.1
Kim, W.2
Moon, S.O.3
-
59
-
-
44449158072
-
Angiopoietin-1 prevents hypertension and target organ damage through its interaction with endothelial Tie2 receptor
-
Lee JS, Song SH, Kim JM, et al,. Angiopoietin-1 prevents hypertension and target organ damage through its interaction with endothelial Tie2 receptor. Cardiovasc Res 2008; 78: 572.
-
(2008)
Cardiovasc Res
, vol.78
, pp. 572
-
-
Lee, J.S.1
Song, S.H.2
Kim, J.M.3
-
60
-
-
66249119474
-
Bench-to-bedside review: Angiopoietin signalling in critical illness - A future target?
-
van Meurs M, Kumpers P, Ligtenberg JJ, Meertens JH, Molema G, Zijlstra JG,. Bench-to-bedside review: Angiopoietin signalling in critical illness-a future target? Crit Care 2009; 13: 207.
-
(2009)
Crit Care
, vol.13
, pp. 207
-
-
Van Meurs, M.1
Kumpers, P.2
Ligtenberg, J.J.3
Meertens, J.H.4
Molema, G.5
Zijlstra, J.G.6
-
61
-
-
9444299031
-
Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: Implications for cardiovascular risk and effects of multifactorial intervention
-
Lim HS, Blann AD, Chong AY, Freestone B, Lip GY,. Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention. Diabetes Care 2004; 27: 2918.
-
(2004)
Diabetes Care
, vol.27
, pp. 2918
-
-
Lim, H.S.1
Blann, A.D.2
Chong, A.Y.3
Freestone, B.4
Lip, G.Y.5
-
62
-
-
41649084937
-
Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension
-
Patel JV, Lim HS, Varughese GI, Hughes EA, Lip GY,. Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension. Ann Med 2008; 40: 215.
-
(2008)
Ann Med
, vol.40
, pp. 215
-
-
Patel, J.V.1
Lim, H.S.2
Varughese, G.I.3
Hughes, E.A.4
Lip, G.Y.5
-
63
-
-
33947584387
-
Anemia is associated with mortality in kidney-transplanted patients-a prospective cohort study
-
Molnar MZ, Czira M, Ambrus C, et al,. Anemia is associated with mortality in kidney-transplanted patients-a prospective cohort study. Am J Transplant 2007; 7: 818.
-
(2007)
Am J Transplant
, vol.7
, pp. 818
-
-
Molnar, M.Z.1
Czira, M.2
Ambrus, C.3
-
64
-
-
57549107880
-
Apelin, a novel adipocytokine, in relation to endothelial function and inflammation in kidney allograft recipients
-
Malyszko J, Malyszko JS, Pawlak K, Wolczynski S, Mysliwiec M,. Apelin, a novel adipocytokine, in relation to endothelial function and inflammation in kidney allograft recipients. Transplant Proc 2008; 40: 3466.
-
(2008)
Transplant Proc
, vol.40
, pp. 3466
-
-
Malyszko, J.1
Malyszko, J.S.2
Pawlak, K.3
Wolczynski, S.4
Mysliwiec, M.5
-
65
-
-
77956231365
-
Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients
-
Ong T, McClintock DE, Kallet RH, Ware LB, Matthay MA, Liu KD,. Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients. Crit Care Med 2010; 38: 1845.
-
(2010)
Crit Care Med
, vol.38
, pp. 1845
-
-
Ong, T.1
McClintock, D.E.2
Kallet, R.H.3
Ware, L.B.4
Matthay, M.A.5
Liu, K.D.6
-
66
-
-
79953218683
-
Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis
-
Ricciuto DR, dos Santos CC, Hawkes M, et al,. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med 2011; 39: 702.
-
(2011)
Crit Care Med
, vol.39
, pp. 702
-
-
Ricciuto, D.R.1
Dos Santos, C.C.2
Hawkes, M.3
-
67
-
-
84881475636
-
Increased serum angiopoietin-2 is associated with abdominal aortic aneurysm prevalence and cardiovascular mortality in older men
-
Golledge J, Clancy P, Yeap BB, Hankey GJ, Norman PE,. Increased serum angiopoietin-2 is associated with abdominal aortic aneurysm prevalence and cardiovascular mortality in older men. Int J Cardiol 2013; 167: 1159.
-
(2013)
Int J Cardiol
, vol.167
, pp. 1159
-
-
Golledge, J.1
Clancy, P.2
Yeap, B.B.3
Hankey, G.J.4
Norman, P.E.5
-
68
-
-
84890034596
-
Circulating angiopoietin-2, its soluble receptor Tie-2, and mortality in the general population
-
Lorbeer R, Baumeister SE, Dorr M, et al,. Circulating angiopoietin-2, its soluble receptor Tie-2, and mortality in the general population. Eur J Heart Fail 2013; 15: 1327.
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 1327
-
-
Lorbeer, R.1
Baumeister, S.E.2
Dorr, M.3
-
69
-
-
3343016654
-
Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor
-
Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH,. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 2003; 6: 283.
-
(2003)
Angiogenesis
, vol.6
, pp. 283
-
-
Kusumanto, Y.H.1
Dam, W.A.2
Hospers, G.A.3
Meijer, C.4
Mulder, N.H.5
|